JP2025516683A5 - - Google Patents

Info

Publication number
JP2025516683A5
JP2025516683A5 JP2024566809A JP2024566809A JP2025516683A5 JP 2025516683 A5 JP2025516683 A5 JP 2025516683A5 JP 2024566809 A JP2024566809 A JP 2024566809A JP 2024566809 A JP2024566809 A JP 2024566809A JP 2025516683 A5 JP2025516683 A5 JP 2025516683A5
Authority
JP
Japan
Prior art keywords
powder
ray diffraction
diffraction pattern
crystalline
profile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024566809A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025516683A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/021986 external-priority patent/WO2023220338A1/en
Publication of JP2025516683A publication Critical patent/JP2025516683A/ja
Publication of JP2025516683A5 publication Critical patent/JP2025516683A5/ja
Pending legal-status Critical Current

Links

JP2024566809A 2022-05-13 2023-05-12 Tyk2阻害剤の結晶形態およびその使用 Pending JP2025516683A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263341528P 2022-05-13 2022-05-13
US63/341,528 2022-05-13
US202263405577P 2022-09-12 2022-09-12
US63/405,577 2022-09-12
PCT/US2023/021986 WO2023220338A1 (en) 2022-05-13 2023-05-12 Crystalline forms of a tyk2 inhibitor and uses thereof

Publications (2)

Publication Number Publication Date
JP2025516683A JP2025516683A (ja) 2025-05-30
JP2025516683A5 true JP2025516683A5 (enExample) 2026-05-18

Family

ID=86760338

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024566809A Pending JP2025516683A (ja) 2022-05-13 2023-05-12 Tyk2阻害剤の結晶形態およびその使用

Country Status (11)

Country Link
EP (1) EP4522602A1 (enExample)
JP (1) JP2025516683A (enExample)
KR (1) KR20250009492A (enExample)
CN (1) CN119907791A (enExample)
AU (1) AU2023269081A1 (enExample)
CA (1) CA3253365A1 (enExample)
CL (1) CL2024003456A1 (enExample)
IL (1) IL317011A (enExample)
MX (1) MX2024014000A (enExample)
TW (1) TW202409007A (enExample)
WO (1) WO2023220338A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202428571A (zh) * 2022-10-10 2024-07-16 美商雅盧米斯公司 Tyk2抑制劑之晶型及其用途
WO2026019902A1 (en) * 2024-07-16 2026-01-22 Alumis Inc. Crystalline forms of a tyk2 inhibitor and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20250048T1 (hr) * 2018-10-22 2025-03-28 Alumis Inc. Inhibitori tyk2 i njihova uporaba

Similar Documents

Publication Publication Date Title
US11697636B2 (en) Substituted benzamides
JP2025176008A5 (enExample)
JP2023519891A5 (enExample)
EP2479165B1 (en) Glycine compound
JP2022543155A5 (enExample)
JPS584752A (ja) カルボキシアミド誘導体及びその製造法
JP2005533860A5 (enExample)
RU2009122241A (ru) Твердые формы рацемического илапразола
JP2022551525A5 (enExample)
BRPI0718546A2 (pt) Formas cristalinas de hemifumarato de alisquireno
WO2012155806A1 (zh) 4-氨基喹唑啉衍生物及其应用
JP2022523368A5 (enExample)
JP2025508071A5 (enExample)
JPH0557983B2 (enExample)
TW200911251A (en) Tetrahydroisoquinolin-1-one derivatives or salt thereof
JP2002528536A (ja) ベンゾイルピリダジン
CA2202484C (en) Use of indole derivatives for the treatment of various diseases
JP2024001040A5 (enExample)
US20100179118A1 (en) Cyclic aminoalkylcarboxamide derivative
JP2025508051A5 (enExample)
JP2024542840A5 (enExample)
JP2024520897A5 (enExample)
JP2022518288A5 (enExample)
JP2025516648A5 (enExample)
WO1993023360A1 (en) Novel quaternary ammonium salts and use thereof as medicine